Symrise bags SFDA approval for its skin brightening ingredient

The Chinese State Food and Drug Administration (SFDA) has approved Germany-based fragrance and cosmetic actives supplier Symrise’s skin-whitening agent, SymWhite, which will provide the firm’s access into the Asian country’s market.

The firm said the new ingredient has been created with inspiration from pinosylvin, which is a natural skin brightening compound, that is extracted from pine trees and has been synthesised and screened for tyrosinase inhibitory activity as well as antioxidant efficacy.

According the firm, the ingredient has been found to improve without side-effects the appearance of dull complexions and boost clarity and brightness, reported website Cosmetic Design.

The company also claims that the ingredient’s efficacy has been tested in vitro, in vivo and ex vivo as well as in a clinical study with Asian subjects showing that 0.5% of SymWhite is a more effective solution for brighter skin compared to 1% kojic acid.

Symrise cosmetic ingredients global business unit senior vice president Dr. Gabriele Vielhaber was quoted by the website as saying that the firm was delighted with the SFDA’s new decision to approve the new ingredient in China.

"Our customers that are active on the Asian market can now develop effective products that fulfill the wish for an even and radiant skin and that give care and protection at the same time, " Vielhaber added.

Global cosmetic companies require SFDA approval before introducing any new cosmetic raw materials into the China.

Image: SymWhite provides brightening effect along with improving the appearance of dull complexions and boost clarity and brightness without any side effects Photo: Symrise AG.